Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Reduced number of insulin producing ?-cells in pancreas due to increased ?-cell death is a key defect in diabetes that eventually leads to elevated blood glucose levels and life-time treatment with glucose lowering drugs or daily insulin injections. Thus, finding therapeutic approaches to prevent the decrease in the number of insulin producing ?-cells in diabetic patients either by reducing ?-cell death or by increasing their proliferation is of great importance. In this study, we will use transformed and primary islet ?-cells, to investigate the effects of five purified natural products (to be provided by Blue-O Medicals Inc.) on ?-cell proliferation, function, and death. The findings of this study may lead to development of new therapeutic approaches to maintain enough number of ?-cells in diabetic patients to keep blood glucose within normal range thereby prevent progression of diabetes.
Lucy Marzban
Queenie Hui
Blue-O Technology Inc.
Medicine
Life sciences
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.